Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation-Reference-Cited by-同舟云学术

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation

Published:2020-12-14 Issue:1 Volume:61 Page:157-169
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Yiangou Andreas¹²³^ORCID,Mitchell James L.¹²³^ORCID,Fisher Claire³,Edwards Julie³,Vijay Vivek¹²³,Alimajstorovic Zerin¹²^ORCID,Grech Olivia¹²^ORCID,Lavery Gareth G.¹²^ORCID,Mollan Susan P.⁴^ORCID,Sinclair Alexandra J.¹²³^ORCID

Affiliation:

1. Metabolic Neurology Institute of Metabolism and Systems Research College of Medical and Dental Sciences University of Birmingham Birmingham UK

2. Centre for Endocrinology Diabetes and Metabolism Birmingham Health Partners Birmingham UK

3. Department of Neurology University Hospitals Birmingham NHS Foundation Trust Birmingham UK

4. Birmingham Neuro‐Ophthalmology Unit Ophthalmology Department University Hospitals Birmingham NHS Foundation Trust Birmingham UK

Funder

Sir Jules Thorn Charitable Trust

Brain Research UK

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14026

Reference51 articles.

1. Idiopathic intracranial hypertension: consensus guidelines on management

2. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics;O'Reilly MW;JCI Insight,2019

3. Headache determines quality of life in idiopathic intracranial hypertension

4. Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial

5. Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical profile and treatment outcomes of idiopathic intracranial hypertension: a multicenter study from Korea;The Journal of Headache and Pain;2024-06-25

2. Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study;The Journal of Headache and Pain;2024-06-04

3. The Pseudotumor Cerebri Syndrome;Neurologic Clinics;2024-05

4. Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension;Cephalalgia;2024-04

5. Developments in targeting calcitonin gene-related peptide;Expert Review of Neurotherapeutics;2024-04